Jun 2026 (Q2 FY26) — Jul 29, 2026
MiMedx Q2 FY26 — Sonera MedTech Acquisition and Wound Care Stabilization
Read the full callMiMedx earnings: last reported Wed, 29 Jul 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 64.4 | −34.7% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -28.7 | −41.2 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -14.8 | −254.3% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
1Y: $6.69 on 17 Oct 2025 → $4.38. High $7.96 (5 Nov 2025), low $3.09 (29 Apr 2026).
Overview
Call summaries
MiMedx Q2 FY26 — Sonera MedTech Acquisition and Wound Care Stabilization
Read the full callEvery analysed call
Financials
Net profit, year on year: −254% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 84 | 93 | 88 | 99 | 114 | 118 | 59 | 64 |
| Operating profit | 11 | 11 | 8 | 12 | 22 | 21 | -16 | -18 |
| Operating margin | 13.3% | 11.9% | 9.3% | 12.6% | 19.5% | 17.9% | −27.2% | −28.7% |
| Interest | 1 | 1 | 0 | 0 | 0 | 0 | 0 | — |
| Profit before tax | 11 | 11 | 9 | 13 | 23 | 22 | -15 | -18 |
| Tax rate | 31.0% | 33.9% | 18.4% | 26.1% | 26.7% | 30.3% | 29.2% | 16.5% |
| Net profit | 8 | 7 | 7 | 10 | 17 | 15 | -11 | -15 |
| EPS ($ per share) | 0.05 | — | 0.05 | 0.07 | 0.11 | — | -0.07 | -0.10 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -77 | -102 | -151 | -162 | -192 | -134 | -91 | -43 |
| Total liabilities | 73 | 133 | 111 | 95 | 97 | 96 | 71 | 86 |
| Fixed assets | 17 | 12 | 11 | 9 | 8 | 7 | 6 | 5 |
| Total assets | 123 | 167 | 202 | 188 | 171 | 239 | 264 | 343 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 36 | -39 | -30 | -2 | -18 | 27 | 66 | 74 |
| Cash from investing | -9 | 1 | -5 | -3 | -3 | -2 | -10 | -7 |
| Cash from financing | -9 | 63 | 62 | -3 | -1 | -9 | -34 | -5 |
| Net cash flow | 18 | 24 | 27 | -9 | -21 | 16 | 22 | 62 |
| Capital expenditure | — | — | — | -3 | -2 | -2 | — | — |
| Free cash flow | — | — | — | -5 | -19 | 25 | — | — |
22 filings between Nov 6, 2025 and Jul 2, 2026.
Purchases
None
No insider bought shares.
Sales
$432.3K
1 sale by 1 insider
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Maersk-Moller Kimberly | — | $432.3K | Nov 6, 2025 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | DOUG RICE Chief Financial Officer | Tax withheld | 12,749 | $50.4K |
| Jun 24, 2026 | Maersk-Moller Kimberly Chief Commercial Officer | Tax withheld | 19,820 | $75.9K |
| Jun 10, 2026 | Olson Tiffany Director | Award | 50,913 | $185.3K |
| Jun 10, 2026 | HAWKINS WILLIAM A Director | Award | 50,913 | $185.3K |
| Jun 10, 2026 | Newton Todd Director | Award | 50,913 | $185.3K |
| Jun 10, 2026 | PUHY DOROTHY E Director | Award | 50,913 | $185.3K |
| Jun 10, 2026 | BIERMAN JAMES L Director | Award | 50,913 | $185.3K |
| Mar 13, 2026 | Hulse William Frank IV General Counsel and CAO | Tax withheld | 20,245 | $88.7K |
| Mar 13, 2026 | Maersk-Moller Kimberly Chief Commercial Officer | Tax withheld | 6,762 | $29.6K |
| Mar 10, 2026 | DOUG RICE Chief Financial Officer | Option exercise | 243,000 | $1.09M |
| Mar 10, 2026 | DOUG RICE Chief Financial Officer | Tax withheld | 96,363 | $433.6K |
| Mar 10, 2026 | Hulse William Frank IV General Counsel and CAO | Option exercise | 136,364 | $613.6K |
| Mar 10, 2026 | Hulse William Frank IV General Counsel and CAO | Tax withheld | 61,460 | $276.6K |
| Mar 10, 2026 | Maersk-Moller Kimberly Chief Commercial Officer | Option exercise | 42,845 | $192.8K |
| Mar 10, 2026 | Maersk-Moller Kimberly Chief Commercial Officer | Tax withheld | 21,270 | $95.7K |
| Mar 4, 2026 | Capper Joseph H Chief Executive Officer | Award | 371,094 | $0 |
| Mar 4, 2026 | DOUG RICE Chief Financial Officer | Award | 74,163 | $0 |
| Mar 4, 2026 | Hulse William Frank IV General Counsel and CAO | Award | 74,987 | $0 |
| Mar 4, 2026 | Whitlow Ricci S Chief Operating Officer | Award | 74,163 | $0 |
| Mar 4, 2026 | Maersk-Moller Kimberly Chief Commercial Officer | Award | 74,163 | $0 |
| Feb 13, 2026 | Whitlow Ricci S Chief Operating Officer | Tax withheld | 61,961 | $317.2K |
| Nov 6, 2025 | Maersk-Moller Kimberly Chief Commercial Officer | Sale | 58,300 | $432.3K |
| Jul 3, 2025 | DOUG RICE Chief Financial Officer | Tax withheld | 12,749 | $80.8K |
| Jun 24, 2025 | Maersk-Moller Kimberly Chief Commercial Officer | Tax withheld | 12,034 | $71.7K |
| Jun 18, 2025 | PUHY DOROTHY E Director | Award | 28,609 | $185.1K |
| Jun 18, 2025 | Olson Tiffany Director | Award | 28,609 | $185.1K |
| Jun 18, 2025 | LAURENCIN CATO T Director | Award | 28,609 | $185.1K |
| Jun 18, 2025 | HAWKINS WILLIAM A Director | Award | 28,609 | $185.1K |
| Jun 18, 2025 | BIERMAN JAMES L Director | Award | 28,609 | $185.1K |
| Jun 18, 2025 | BEHRENS M KATHLEEN Director | Award | 28,609 | $185.1K |
| May 2, 2025 | Capper Joseph H Chief Executive Officer | Purchase | 200,000 | $1.27M |
| Apr 23, 2025 | Hulse William Frank IV General Counsel and CAO | Tax withheld | 8,876 | $60.0K |
| Apr 8, 2025 | Hulse William Frank IV General Counsel and CAO | Tax withheld | 8,876 | $60.9K |
| Apr 1, 2025 | Maersk-Moller Kimberly Chief Commercial Officer | Tax withheld | 1,761 | $13.2K |
| Mar 17, 2025 | Maersk-Moller Kimberly Chief Commercial Officer | Sale | 1,759 | $14.1K |
| Mar 13, 2025 | Hulse William Frank IV General Counsel and CAO | Sale | 20,366 | $160.7K |
| Mar 13, 2025 | Maersk-Moller Kimberly Chief Commercial Officer | Sale | 4,106 | $32.4K |
| Mar 13, 2025 | Hulse William Frank IV General Counsel and CAO | Sale | 34,230 | $270.1K |
| Mar 10, 2025 | Hulse William Frank IV General Counsel and CAO | Sale | 81,446 | $635.3K |
| Mar 3, 2025 | Maersk-Moller Kimberly Chief Commercial Officer | Award | 45,929 | $0 |
| Mar 3, 2025 | Capper Joseph H Chief Executive Officer | Award | 223,268 | $0 |
| Mar 3, 2025 | DOUG RICE Chief Financial Officer | Award | 45,929 | $0 |
| Mar 3, 2025 | Hulse William Frank IV General Counsel and CAO | Award | 76,510 | $0 |
| Mar 3, 2025 | Hulse William Frank IV General Counsel and CAO | Award | 46,439 | $0 |
| Mar 3, 2025 | Whitlow Ricci S Chief Operating Officer | Award | 45,929 | $0 |
| Feb 28, 2025 | Maersk-Moller Kimberly Chief Commercial Officer | Sale | 2,111 | $17.7K |
| Feb 13, 2025 | Whitlow Ricci S Chief Operating Officer | Sale | 61,420 | $508.6K |
| Dec 11, 2024 | Maersk-Moller Kimberly Chief Commercial Officer | Award | 125,581 | $0 |
| Jun 18, 25 | Newton Todd Director | Award | 28,609 | $185.1K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow MIMEDX GROUP, INC. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading